Home / Market News / $CRL
benzinga Corporate Catalyst Impact 55/100 ● positive

Charles River Laboratories and Autolomous Launch Apollo Orchestrate To Digitize Laboratory Execution Through autoloMATE Integration

Oct 6, 2026, 12:13 PM UTC · Primary ticker $CRL

Charles River Laboratories (CRL) has launched Apollo Orchestrate, a new digital laboratory execution capability developed with Autolomous, to modernize and digitize its lab workflows. This initiative aims to improve efficiency, compliance, and scalability in its Biologics Testing Solutions sites, integrating with existing systems like LabWare LIMS for enhanced traceability.

Charles River Laboratories (CRL) announced the launch of Apollo Orchestrate, a new digital laboratory execution system developed in partnership with Autolomous. This system, built on Autolomous's autoloMATE, aims to digitize and automate laboratory workflows, particularly in quality control testing within GMP settings across CRL's North American and European Biologics Testing Solutions sites. This move signifies CRL's strategic commitment to modernization and digitization, which could lead to improved operational efficiency, enhanced compliance, and greater scalability in its services. For CRL, this represents a long-term opportunity to streamline operations and potentially attract more clients seeking advanced, digitally integrated testing solutions, though the immediate market impact is likely moderate as it's an operational improvement rather than a major financial event.

$CRL positive Enhances operational efficiency and service offerings
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.